Kits Eyecare (TSE:KITS) has released an update.
Kits Eyecare Ltd. has upsized its secondary offering from $10.15 million to $11.4 million, with an over-allotment option that could bring additional proceeds if fully exercised. The offering, led by Canaccord Genuity Corp., involves the sale of common shares held by key shareholders and is expected to close by September 26, 2024. Concurrently, there’s a bought deal for additional shares from a block shareholder, not contingent on the main offering’s completion.
For further insights into TSE:KITS stock, check out TipRanks’ Stock Analysis page.
